BlackRock, Inc. Increases Stake in Jade Biosciences Inc.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an increased ownership in Jade Biosciences Inc. As of September 30, 2025, BlackRock owns 2,150,203 shares of common stock, representing a 6.6% ownership stake. This marks an increase of 435,855 shares from the previous filing, reflecting a 25.424% rise in share ownership. The value of the holdings has also increased by 17.6399% to $20,147,402.11. BlackRock, Inc. has stated that the shares were acquired in the ordinary course of business and not for the purpose of influencing the control of the issuer. The filing also includes certifications and exhibits, such as a Power of Attorney and details on subsidiary identification.